111, Inc. to Participate in Fireside Chat with Water Tower Research on March 26, 2025

Rhea-AI Summary

111, Inc. (NASDAQ: YI) has announced its participation in an upcoming fireside chat with Water Tower Research on March 26, 2025 at 11:00 a.m. ET. The event will feature Co-Founder, Chairman, and CEO Junling Liu discussing several key topics:

• Q4 2024 earnings results (to be reported on March 20, 2024)
• Company priorities and goals for 2025
• Updated overview of the macroenvironment

The tech-enabled healthcare platform company, focused on digitally transforming China's healthcare value chain, will host this listen-only event with WTR's senior research analyst Robert Sassoon. A replay will be available in the events section of 111's investor relations website at http://ir.111.com.cn/.

SHANGHAI, March 12, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, March 26, 2025 at 11:00 a.m. ET.

Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q4 2024 earnings (to be reported on Thursday, March 20, 2024), its priorities and goals for 2025, and an updated overview of the macroenvironment.

To register for this listen-only event, please visit:
Fireside Chat Registration Link

The replay of the fireside chat will be available under "Events" in the 111's investor relations website at http://ir.111.com.cn/.

Forward-Looking Statements

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Among other things, the Business Outlook and quotations from management in this announcement, as well as 111's strategic and operational plans, contain forward-looking statements. 111 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company's ability comply with extensive and evolving regulatory requirements, its ability to compete effectively in the evolving PRC general health and wellness market, its ability to manage the growth of its business and expansion plans, its ability to achieve or maintain profitability in the future, its ability to control the risks associated with its pharmaceutical retail and wholesale businesses, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and 111 does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring. For more information on 111, please visit: http://ir.111.com.cn/.

 

View original content:https://www.prnewswire.com/news-releases/111-inc-to-participate-in-fireside-chat-with-water-tower-research-on-march-26-2025-302399561.html

SOURCE 111, Inc.

FAQ

When will YI report its Q4 2024 earnings?

111, Inc. (YI) will report its Q4 2024 earnings on Thursday, March 20, 2024.

What topics will be covered in YI's March 26 fireside chat?

The fireside chat will cover Q4 2024 earnings results, company priorities and goals for 2025, and an updated macroenvironment overview.

Who will represent YI in the Water Tower Research fireside chat?

Junling Liu, Co-Founder, Chairman, and CEO of 111, Inc. will participate in the fireside chat.

How can investors access YI's fireside chat replay?

The replay will be available under the 'Events' section on 111's investor relations website at http://ir.111.com.cn/.

What is YI's main business focus in China?

YI is a tech-enabled healthcare platform company working to reshape the healthcare industry value chain through digital empowerment of upstream and downstream operations in China.